Work

Phase I study of high-dose topotecan with haematopoietic stem cell support in the treatment of ovarian carcinomas: the ITOV 01 protocol

Year: 2006

Type: article

Study design: Clinical Trial

Source: Bone Marrow Transplantation

DOI: 10.1038/sj.bmt.1705310

Authors: J-P Lotz, P Pautier, F Selle, P Viens, M Fabbro, F Lokiec, F Viret, J Gligorov, B Gosse, S Provent, V Ribrag, J-M Micléa, C Dosquet, A Goetschel, C Cailliot, G Lefèvre, J Genève, C Lhommé, on behalf of the Groupe d'Intensification des traitements des Tumeurs Ovariennes (ITOV Group)

Institutions: Assistance Publique – Hôpitaux de Paris, Hôpital Tenon, Université Pierre-et-Marie-Curie, Institut Gustave Roussy, Institut Paoli-Calmettes, Hôpital René Huguenin, Hôpital Saint-Louis, GlaxoSmithKline (France), La Ligue Contre le Cancer

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, GlaxoSmithKline

OpenAlex ID: W2069285282

FWCI: 0.187

Cites: 37

Cited by: 5

Related to: 10